A Feasibility study of Pemetrexed single agent and folic acid given as neoadjuvant treatment in patients with resectable rectal cancer

Update Il y a 4 ans
Reference: EUCTR2005-005929-62

Woman and Man

  • | Country :
  • -
  • | organs :
  • -
  • | Specialty :
  • -

Extract

To evaluate the feasibility of three neo-adjuvant cycles of single agent Pemetrexed at 500 mg/m2 q3w prior to surgery with or without radiotherapy in patients with resectable rectal cancer.


Inclusion criteria

  • neoadjuvant treatment in chemo-naive patients with newly diagnosed operable rectal cancer

Links